Clinical Trial

Use of Physiology to Evaluate Procedural Result After PCI CTO

Study acronym: ULTRA-CTO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 19, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
ULTRA-CTO is a prospective multicentre non-randomised investigator-initiated trial designed to enrol 200 subjects with an indication for percutaneous coronary intervention (PCI) of chronic total occluded (CTO) coronary artery. The main objective of the study is to assess the predictive value of post-PCI resting full-cycle ratio (RFR) and fractional flow reserve (FFR) with regard to Fractional flow reserve (SSR) in CTO patients.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-03-02; most recent amendment 2025-02-15.
Status change: Not Yet Recruiting → Recruiting 2021-08-30
Trial Details
NCT Number NCT04780971
Lead Sponsor Isala
Collaborators: Abbott
Conditions Percutaneous Coronary Revascularisation, Complex Coronary Lesion
Enrollment 200 participants
Start Date 2021-07-21
Primary Completion 2026-05 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-19